Related Experiment Videos
Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure
The American Journal of Cardiology
|February 1, 1983
Insights
Outpatient dobutamine infusions improved heart function in patients with severe congestive heart failure (CHF). This portable pump therapy resolved CHF symptoms with minimal side effects over 58 weeks.
Area of Science:
- Cardiology
- Pharmacology
- Medical Devices
Background:
- Intractable congestive heart failure (CHF) poses significant management challenges.
- Limited effective outpatient treatment options exist for advanced CHF.
Observation:
- Three patients with severe CHF received outpatient dobutamine infusions via a portable pump.
- Infusions were administered twice weekly to improve tolerance.
Findings:
- Significant improvement in left ventricular function was observed in all patients.
- Complete resolution of congestive heart failure symptoms occurred.
- Therapy was well-tolerated, with only minor catheter site infections reported over 58 cumulative patient weeks.
Implications:
- Outpatient dobutamine infusions represent a viable therapeutic strategy for managing intractable CHF.
- Portable infusion pump technology facilitates home-based treatment, enhancing patient quality of life.
- This approach may reduce hospitalizations and improve long-term outcomes for CHF patients.
Abstract:
The use of outpatient dobutamine infusions by a small, portable infusion pump in 3 patients with intractable congestive heart failure (CHF) is described. With this therapy left ventricular function improved and CHF resolved in each. Tolerance to dobutamine was obviated by giving infusions twice weekly. Except for 3 mild infections around the catheter exit site, there have been no complications of this therapy is 58 cumulative patient weeks.